Home › Funds › BML Capital Management, LLC › AVIR

BML Capital Management, LLC position in AVIR

ATEA PHARMACEUTICALS INC · Health Care

BML Capital Management, LLC reported holding 6,753,658 shares of AVIR (ATEA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$35.2M, representing 18.75% of its reported portfolio and ranking #2 among its reported holdings. BML Capital Management, LLC has disclosed AVIR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)6.75M sh
Reported value held$35.19M
Portfolio Weight18.75%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BML Capital Management, LLC's AVIR position evolved

BML Capital Management, LLC first disclosed a stake in AVIR in Q3 2023 at 4,800,000 shares (US$14.4M). The position peaked in Q1 2026 at 7,058,657 shares, worth US$38.0M. Across 13 filings, BML Capital Management, LLC increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 6,753,658 shares valued at US$35.2M — a reduction of -198,672 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.80M $14.40M New
Q4 2023 5.46M $16.66M Add
Q1 2024 5.54M $22.37M Add
Q2 2024 6.38M $21.10M Add
Q3 2024 6.65M $22.28M Add
Q4 2024 7.61M $25.49M Add
Q1 2025 7.61M $22.75M Hold
Q2 2025 7.61M $27.40M Hold
Q3 2025 7.47M $21.67M Reduce
Q4 2025 7.49M $26.74M Hold
Q1 2026 7.06M $37.98M Reduce
Q2 2026 6.95M $32.33M Reduce
Q3 2026 6.75M $35.19M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVIR and 13F data

AVIR (ATEA PHARMACEUTICALS INC) is a Health Care company. 29 other funds we track also report a position in AVIR — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$22.4M), Bain Capital Life Sciences Investors, LLC (US$9.7M), Rosalind Advisors, Inc. (US$5.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVIR

All AVIR fund holders →

FAQ

How long has BML Capital Management, LLC held AVIR?

BML Capital Management, LLC has disclosed AVIR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BML Capital Management, LLC's current position in AVIR?

As of Q3 2026, BML Capital Management, LLC holds 6.75M shares of AVIR (ATEA PHARMACEUTICALS INC), valued at $35.19M, representing 18.75% of its reported portfolio and ranking #2.

Has BML Capital Management, LLC been buying or selling AVIR?

In the latest 13F filing (Q3 2026), BML Capital Management, LLC reduced its position in AVIR. The position peaked in Q1 2026 at 7.06M shares.

Which other funds hold AVIR?

Other major institutional holders of AVIR include TANG CAPITAL MANAGEMENT LLC, Bain Capital Life Sciences Investors, LLC, Rosalind Advisors, Inc., among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.